Genscript Biotech Corp (1548.HK)
Get access to over 18 million research reports from over 1,700 sources.
For several years, Reuters.com has provided analyst research reports for downloading. In an effort to streamline our website, analyst research will now be available from our dedicated page for Thomson Reuters On Demand, and the Reuters service will discontinue as of September 30, 2016.
Thomson Reuters On Demand provides over 18 million research reports from 1,700 sources.
Moreover, Thomson Reuters On Demand offers fast and cost-effective solutions that would allow you to retrieve information on:
- private equity
- third-party document and information retrieval
- and much, much more…
Click here to request a report and the team of expert analysts will get back to you shortly, to ensure you get the report you need.
|51||2015||Executive Chairman of the Board, Chief Executive Officer|
|47||2015||Chief Operating Officer, Executive Director|
|47||2015||Vice President - Finance, Executive Director|
|66||2010||Vice President - Strategy|
|46||2014||Senior vice President - Public Relation Department|
- BRIEF-Genscript Biotech Announces Unit Received Permission Of Clinical Trial Granted By China FDA
- BRIEF-Genscript Biotech Says Huang Zuie-Chin Resigns As Non-Executive Director
- BRIEF-Genscript Biotech Announces Acquisition Of Customarray
- BRIEF-Genscript Biotech Says US, Ireland Units & Janssen Biotech Enter Collaboration & License Agreement
- BRIEF-Janssen Enters Collaboration And License Agreement With China's Legend Biotech To Develop CAR-T Cancer Therapy